CAR T-cell therapy must be treated as a complete "vein-to-vein" episode, with community practices needing to take control of cases for a period of time.
Feature|Articles|January 27, 2026 (Updated: February 3, 2026)
Population Health, Equity & Outcomes
- March 2026
- Volume 32
- Issue Spec. No. 3
- Pages: SP192-SP194
Experts Warn That CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust
Author(s)Brooke McCormick
Fact checked by: Julia Bonavitacola
Experts raise concerns that CDC childhood immunization changes could reduce vaccine uptake and weaken trust in public health guidance.
Advertisement
Advertisement
Am J Manag Care. 2026;32(Spec. No. 3):SP192-SP194.
Related to this article
A scoping review of 15 studies found psoriasis prevalence markedly lower across 13 indigenous populations worldwide.
CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
Among people with HIV, lung cancer screening eligibility rose from 6% to 15% in 6 years, but uptake stayed under 30%.
FDA accepted United Therapeutics' sNDA for inhaled treprostinil in IPF. Here's what it could mean for patient access, coverage, and costs
Sustainable models require asking what a result shows, what design produced it, and whether the design was built to measure value or just produce a number.
Hepatitis reports after vaccination were more often serious in children, but the data lack dose counts and cannot show vaccine-specific risk.
CMS finalized Transparency in Coverage updates as a researcher warns ghost rates and missing inpatient data limit payer price files.
Advertisement
Advertisement